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Risk Factors for Local Tumor Recurrence
after Segmental Transarterial
Chemoembolization for Hepatocellular
Carcinoma: the Importance of Tumor
Located in the Segmental Border Zone
Objective: We wanted to evaluate whether tumors located in a segmental bor-
der zone are predisposed to local recurrence after performing segmental transar-
terial chemoembolization for hepatocellular carcinoma.
Materials and Methods: Seventy-three hepatocellular carcinoma nodules
were retrospectively analyzed for local tumor recurrence after performing seg-
mental transarterial chemoembolization by using follow-up CT studies (median
follow-up period: 20 months, range: 4 77 months). The tumors were divided into
two groups according to whether the lesions were located at the segmental bor-
der zone (Group I) or not (Group II). Comparison of the tumor characteristics and
chemoembolization methods between the two groups was performed using the
chi-square test. The local recurrence rates were compared by Kaplan-Meyer
method and analyzed with the log rank test.
Results: Local tumor recurrence occurred for 25 hepatocellular carcinoma
nodules (42.9%). The follow-up periods, tumor characteristics and chemoem-
bolization methods between Groups l and ll were comparable. The local recur-
rence rate was 64.0% (16/25) in Group I and 18.8% (9/48) in Group II. The differ-
ence was statistically significant on the univariate and multivariate analyses (p =
0.000 for both).
Conclusion: Tumor location in a segmental border zone was a significant risk
factor for local tumor recurrence after performing segmental transarterial
chemoembolization for hepatocellular carcinoma.
urgical resection or transplantation has been considered the treatment of
choice for hepatocellular carcinoma (HCC) in the patients who are
candidates for surgery (1, 2). However, transcatheter arterial chemoem-
bolization (TACE) is now widely used in the cases of surgically unresectable HCC (3
8). The prognostic factors of local HCC tumor recurrence after TACE are well known,
such as the tumor size or the homogeneity of iodized oil uptake (9, 10). However, at
our medical center, we found that tumors located in the segmental border zone had a
tendency to show more frequent local tumor recurrence after TACE. To the best of
our knowledge, location of tumor in the segmental border zone has not been reported
as a significant prognostic factor of local tumor recurrence after segmental TACE in
any of the English medical literature. In this study, we tried to analyze whether tumor
located in the segmental border zone was significantly associated with local HCC
tumor recurrence after performing segmental TACE. 
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SMATERIALS AND METHODS
Patients Selection
From July 1998 to August 2004, 272 patients with HCC
were referred to our center for TACE. Among them, 107
patients who had hypervascular tumors observed on their
hepatic angiogram and less than four nodules were treated
with segmental TACE. Among these 107 patients, four
patients who had extrahepatic tumor invasion and three
patients who had evidence of hepatic or portal vein tumor
thrombosis were all excluded from the analysis. Another
15 patients were eventually lost during follow-up. Among
the remaining patients, 27 patients displayed residual
enhanced areas within or around the tumors on the one
month follow-up CT imaging, and they subsequently
received other treatments for their liver masses such as
repeated TACE or radiofrequency tissue ablation therapy
(RFAT); these 27 patients were also excluded from the
analysis. So finally, 58 patients with 73 HCC nodules were
included in our study. The median follow-up period was 20
months (range: 4 77 months). 
All the patients except one were males. Their ages
ranged from 44 to 77 years (mean SD: 62.2 9.3 years).
The tumor size ranged from 1.0 cm to 7.3 cm (mean SD:
3.0 1.4 cm). The other characteristics are shown in Table
1. 
The diagnosis of HCC was proved histopathologically for
seven patients. For the other patients, the diagnosis was
established on the basis of the characteristic imaging
findings on the three-phase helical CT and conventional
angiography and/or by the presence of elevated levels of
tumor markers in the blood serum (alpha-fetoprotein level
> 200 ng/mL) (11). In the vast majority of patients, the
etiology of cirrhosis was chronic viral hepatitis B or hepati-
tis C (Table 1).
Chemoembolization Techniques 
All patients had enhanced dynamic CT images taken
within four weeks prior to TACE. All the TACE
procedures were performed by an interventional radiolo-
gist with over five years experience (Y.K.C). Hepatic
angiography was performed using 5 Fr angiographic
catheters; this was followed by superselection of the
segmental arterial feeders using a microcatheter
(Microferret ; Cook, Bloomington, IN). We then adminis-
tered iodized oil-doxorubicin hydrochloride (Adriamycin;
Kyowa Hakko Kogyo, Tokyo, Japan) emulsion into the
feeders. The volume of iodized oil ranged from 3 to 10 ml.
Once the flow became sluggish, gelatin sponge particles
(Gelfoam; Upjohn, Kalamazoo, MI) that were mixed with
contrast material (Iopromide; Schering, Germany) were
administered into the feeders until the blood flow stopped
completely. While performing segmental TACE, attempts
were made to completely occlude the arterial feeders. A
small amount of saline solution was then slowly injected to
confirm the complete occlusion of the segmental arterial
feeder. If the retained contrast media was partially washed
out after the saline injection, additional gelatin sponge
particles were infused until complete stasis of flow was
obtained. 
Among the 73 nodules, four nodules were supplied by
two segmental arteries, as was determined on selective
angiography with using a microcatheter. In these circum-
stances, both segmental feeding arteries were embolized.
Analysis of Risk Factors for Local Tumor Recurrence
and the CT Interpretation
The local recurrence rate was analyzed for nine possible
prognostic factors: patient age, hepatitis C infection, the
modified Child-Pugh classification, the number of tumors,
size of the tumor nodule, the serum alpha-fetoprotein
level, homogeneity of the iodized oil accumulation within
the nodule, tumor location in a segmental border zone and
the tumor growth pattern. 
The number of tumors was determined on the pre-
embolization CT. Tumor size was determined as the
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Table 1. The Patients’ and Tumors’ Characteristics
Characteristics No. %
Age (yrs)
< 60 27 46.6
60 31 53.4
Underlying causes
Hepatitis B 38 65.5
Hepatitis C 13 22.4
Others 07 12.1
Modified Child-Pugh class
A 43 74.1
B 15 25.9
Serum alpha-fetoprotein level
40 ng/mL 35 60.3
40 400 ng/mL 11 19.0
> 400 ng/mL 12 20.7
Number of tumors
Single 38 65.5
Double 14 24.1
Triple 06 10.4
Tumor maximal diameter (cm)
3 35 60.3
3 5 16 27.6
> 5 07 12.1maximal diameter of the nodule that was measured on the
preembolization CT.
The CT examinations were performed with an 8-slice
multidetector CT scanner (Lightspeed; GE Medical
Systems, Milwaukee, WI) with 5-mm collimation and 17.5-
mm/sec table speed, or with a single-detector helical
scanner (Prospeed Advantage; GE Medical Systems,
Milwaukee, WI) with 10-mm collimation and a 10-mm/sec
table speed.
The border zone between the hepatic segments was
determined by tracing the portal venous tree on the portal
phase scan of the spiral CT (12, 13). The segmental border
zone was defined as an area without traceable portal veins
between the hepatic segments on the CT scan. Segmental
border zone lesions were defined as lesions crossing the
imaginary border between the hepatic segments.
All the patients underwent both non-enhanced and
contrast-enhanced three-phase helical CT four weeks after
TACE. The pattern of iodized oil accumulation in the
masses was evaluated with using the four-week follow-up
CT scan. When the tumor nodules showed compact
iodized-oil accumulation without any defect, they were
classified as a “homogeneous” pattern. Otherwise, they
were classified as an “inhomogenous” pattern.
When the tumor nodules showed sharp definition from
the surrounding liver parenchyma without any evidence of
adjacent satellite nodules, they were classified as
“nodular” tumors. Otherwise, they were classified as
“nonnodular” tumors.
Residual viable tumor was judged to be present when an
enhanced portion was seen within or around of the original
mass on the one-month follow-up CT scan. If no definite
evidence of residual tumor was noted on this one-month
follow-up CT, then 3-phase contrast-enhanced CT was
performed at 3- or 4-month intervals thereafter. Local
tumor recurrence was judged to be present when we
observed disappearance of iodized oil from the lesion, or
when an enhanced portion was seen within or at the
margin of the original mass on the next follow-up CT scan
that was done after the first one-month follow-up CT scan.
For the recurred tumors, additional therapies such as
TACE or RFAT were performed.
Two abdominal radiologists with five and four years of
experience, respectively, (Y.O.P., Y.S.A.) interpreted the
CT images; they independently determined the segmental
zonal anatomy, and they were kept unaware of whether
the tumor showed local tumor recurrence on the follow-up
CT images. Final decisions were reached by consensus. 
Statistical Analysis 
Univariate and multivariate analysis was performed
using Kaplan-Meyer estimation and Cox proportional
hazard model for the nine possible prognostic factors of
local tumor recurrence. The parameters that proved to be
significant on the univariate analysis were then
subsequently tested with the multivariate Cox proportional
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Table 2. Possible Risk Factors Contributing to Local Recurrence
Number of Recurred Nodules 
(Total No.: 73)
Percentage (%) p values
Age 60 years 14/37 45.2% 0.587
< 60 years 11/36 40.5%
Hepatitis C Negative  20/58 34.5% 0.684
Positive 05/15 33.3%
Child classification A  18/53 34.0% 0.238
B 07/20 35.0%
Serum alpha-fetoprotein 40 ng/mL 14/41 34.1% 0.477
> 40 ng/mL 11/32 34.4%
Tumor size (cm) 3 cm 15/44 34.1% 0.898
> 3 cm 10/29 34.5%
Number of nodules Single  14/39 35.9% 0.627
Multiple 11/34 32.4%
Tumor growth pattern Nodular 18/59 30.5% 0.352
Nonnodular 07/14 50.0%
Tumor location in segmental border zone No 9/48 18.8% 0.000*
Yes 16/25 64.0%
Iodized oil uptake pattern Homogeneous 8/44 18.2% 0.000*
Note. Statistically significant (p < 0.05)
The local recurrence rates were compared by the Kaplan-Meyer method and then analyzed with the log rank test. hazard model.
Specifically, the tumors were divided into two groups
according to whether the lesions were located at the
segmental border zone (Group I) or not (Group II). Tumor
characteristics such as tumor size, the tumor growth
pattern, the iodized oil uptake pattern on the one-month
follow-up CT imaging and the follow-up periods were
compared between the two groups. The local tumor
recurrence rates were also compared between the two
groups.
Comparison of the tumor characteristics and TACE
methods between the two groups were performed using
the Chi-square test. The local recurrence rate was
compared between the two groups by the Kaplan-Meyer
method and it was analyzed with the log rank test. 
P-values less than 0.05 were considered statistically
significant. The SPSS software package (Version 10.0;
SPSS Inc., Chicago, IL) was used for the statistical analysis. 
RESULTS
The median CT follow-up period was 20 months (range:
4 77 months). Local tumor recurrence occurred for 25
HCC nodules among the 73 nodules (34.2%). Kaplan-
Meyer estimation and log-rank testing revealed that among
the nine possible prognostic factors, tumor location in a
segmental border zone and the iodized oil uptake pattern
within the nodule were significantly associated with local
recurrence (p = 0.000 for both). However, other factors
such as tumor size, the tumor growth pattern, patient age,
the modified Child-Pugh classification, hepatitis C or
serum alpha-fetoprotein level were not significantly associ-
ated with local tumor recurrence (Table 2). Multivariate
analysis also revealed that the iodized oil uptake pattern
and a tumor location in a segmental border zone had a
statistically significant adverse effect on local tumor
recurrence (p = 0.000 and 0.001, respectively). 
There were 25 lesions in a segmental border zone
(Group I) and 48 lesions that were not in a segmental
border zone (Group II) (Figs. 1, 2). The comparison of
tumor characteristics and follow-up periods between the
two groups is presented in Table 3. Although the average
tumor size in Group I tended to be larger than that of
Group II (p = 0.122), there was no statistically significant
difference in the iodized-oil accumulation pattern, the
tumor growth pattern and the median follow-up period
between the two groups (Table 3).
Among the 12 small tumors  3 cm in size in Group I,
five showed homogeneous iodized oil accumulation and
the other seven showed inhomogeneous iodized oil
accumulation. Among the 13 larger tumors > 3 cm in size
in Group I, eight showed homogeneous iodized oil
accumulation and the other five showed inhomogeneous
iodized oil accumulation. Among the 32 small tumors  3
cm in size in Group II, 20 tumors showed homogeneous
iodized oil accumulation and the other 12 tumors showed
inhomogeneous iodized oil accumulation. Among the 16
larger tumors > 3 cm in size in Group II, 11 tumors showed
homogeneous iodized oil accumulation and the other five
showed inhomogeneous iodized oil accumulation. The Chi-
Cho et al.
270 Korean J Radiol 7(4), December 2006
Table 3. Comparison of Tumor Characteristics Between Lesions Located in a Segmental Border Zone and Those Lesions
Located Inside a Hepatic Segment
Group I (Tumors in Segmental  Group II (Tumors inside 
Border Zone) a Hepatic Segment) Odds ratio p values
n = 25 (%) n = 48 (%)
Tumor size
<=3 cm 12 48.0 32 66.7 2.17 (0.81 5.82) 0.122
> 3 cm 13 52.0 16 33.3
average(cm) 3.5 2.8
Iodized oil uptake pattern
Homogeneous 13 52.0 31 64.6 1.68 (0.63 4.50) 0.297
Inhomogeneous 12 48.0 17 35.4
Tumor growth pattern
Nodular 21 84.0 38 79.2 1.38 (0.39 4.95) 0.619
Nonnodular 4 16.0 10 20.8
Follow-up periods
< 24 months 14 56.0 28 58.3 1.10 (0.41 2.92) 0.848
24 months 11 44.0 20 41.7
Median follow-up period (M) 20 21
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Fig. 1. A 73-year-old woman with hepatocellular carcinoma.
A. Pre-embolization CT imaging on the arterial phase reveals a well-defined enhanced mass measuring 2.9 cm in segment 8 of the liver
(arrowhead). The low density lesion in the left lobe dome area is a benign cystic lesion without any interval change over a year (arrow). 
B. Pre-embolization CT imaging on the portal venous phase reveals the same mass with heterogeneous contrast enhancement
(arrowhead).
C. Pre-embolization hepatic angiogram shows the mass with heterogeneous hypervascularity (arrowhead).
D. Post-embolization hepatic angiogram shows the mass without evidence of hypervascular tumor staining. Note that the segmental
arterial feeder was also completely occluded. 
E. One-month follow-up CT imaging shows the mass with inhomogeneous iodized oil accumulation (arrowhead).
F. Seven-month follow-up CT imaging reveals the mass with shrinkage (arrowhead). No definite evidence of local tumor recurrence was
noted. 
EFCho et al.
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Fig. 2. A 70-year-old man with hepatocellular carcinoma.
A. Pre-embolization CT imaging on the portal phase reveals a large well-defined mass measuring 5.1 cm in the S5 segment (arrow).
Portal and delayed phase CT imaging (not shown) revealed delayed marginal rim enhancement, which is a typical finding of hepatocellu-
lar carcinoma.
B. Pre-embolization CT imaging on the portal phase at the level of segmental border zone area between segments 5 and 8. Note that
the upper portion of the tumor is also seen at this level (arrowheads). Therefore, this tumor was regarded as located in the segmental
border zone between S5 and S8.
C. Pre-embolization hepatic angiogram shows the mass with hypervascularity (arrowhead). Note the segmental arterial feeder of the
tumor (arrowhead). A minor blood supply to the tumor from the adjacent segmental artery was also confirmed (not shown).
D. Post-embolization hepatic angiogram reveals no evidence of residual hypervascular tumor staining. Note that the right hepatic artery
is completely occluded.
E. One-month follow-up CT imaging shows the mass with inhomogeneous iodized oil accumulation at the segmental border zone of S5
and S8 (arrowhead). The high density area within the tumor was also seen on the precontrast CT imaging (not shown here).
F. Seven-month follow-up hepatic angiogram reveals the tumor with local recurrence. Note that the original segmental feeders are
completely occluded (arrowheads). Chemoembolization was performed for this mass.
EFsquare test revealed no statistically significant correlation
between the tumor size and the iodized oil accumulation
patterns in each group. 
The period of local tumor recurrence after TACE ranged
from three months to 32 months (mean SD: 9 7
months). The median period of local recurrence was seven
months. In Group I, the median period of local recurrence
was seven months (range: 3 20 months). In Group II, the
median period of local recurrence was eight months (range:
4 32 months). In Group I, the 1-year and 3-year
estimated local tumor recurrence rates were approximately
51.5% and 79.2%, respectively. In Group II, the 1-year
and 3-year estimated local tumor recurrence rates were
18.6% and 34.9%, respectively. The difference in the local
tumor recurrence rates between the two groups was statis-
tically significant (p = 0.000) (Fig. 3), which means Group I
showed a higher local tumor recurrence rate compared to
Group II. For the Group II lesions with homogeneous
iodized oil accumulation, the estimated 1-year and 3-year
local tumor recurrence rates were 6.5% and 22.0%,
respectively.
Among the 25 patients with local tumor recurrence after
segmental TACE, 14 patients underwent follow-up hepatic
angiography. Among the 14 patients, only three patients
showed reopening of the originally occluded segmental
arterial feeders, and all the other patients showed no
evidence of reopening of the originally occluded segmental
arteries (Fig. 2). 
To treat the local recurred tumors, we performed
radiofrequency tissue ablation therapy for six nodules,
TACE for 15 nodules and surgical resection for one
nodule. The other three nodules were conservatively
treated because of poor liver function or the patients
refused further treatment. Fifteen of the 22 recurred
tumors that were treated showed no evidence of residual
viable tumor on the follow-up CT scan. The estimated 1-
year and 3-year overall survival rates were 81.6% and
68.0%, respectively. At the end of the study, 25 patients
had expired. And among them, eight patients died of
recurrent HCC. 
DISCUSSION
The risk factors of local HCC tumor recurrence after
segmental TACE are well known (9, 10). The same as for
other studies, the present study also showed that the local
tumor recurrence rate was higher for the tumors showing
inhomogeneous iodized oil uptake. However, it has not
been clearly reported until now whether or not tumor
location in a segmental border zone is associated with local
tumor recurrence after performing segmental TACE.
In this study, tumor location in a segmental border zone
was proved to be another risk factor for local tumor
recurrence after segmental TACE for HCC by both the
univariate and multivariate analyses. Most of the recurrent
tumors were supplied by feeders from the adjacent
segmental arteries, and most of the originally occluded
segmental arteries had not reopened, as was seen on the
follow-up hepatic angiograms. 
One of the reasons why Group I showed a higher local
recurrence rate may be that there were more chances for
missing the fine arterial feeders from the adjacent segmen-
tal arteries. The other possible reason may that the
recurred tumors might have survived via their portal vein
supply after performing segmental TACE (14). The collat-
eral vessels would probably develop from the adjacent
segmental arteries for these tumors, but the shortest
distance between Group I and adjacent segmental arteries
was shorter than that between Group II and the adjacent
segmental arteries. This would have caused earlier tumor
recurrence for Group I. 
In this study, tumor size was not associated with local
tumor recurrence. This finding stands in contrast to other
previous studies (9, 10), and it may have been caused by
the fact that only the tumors treated with segmental TACE
were included in our study, and relatively strict measures
of segmental tumor feeder occlusion were applied in most
of the cases. In this study, the tumor growth pattern was
not also significantly associated with local tumor
recurrence. This finding may have been caused by the fact
that the segmental arteries were completely occluded in
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Fig. 3. Comparison of local tumor recurrence rates between
tumors located in segmental border zones (n = 25) and those
located inside the hepatic segments (n = 48). Tumors located in
segmental border zones showed earlier local tumor recurrence
compared to those tumors located inside hepatic segments on
the univariate and multivariate analyses with using Kaplan-Meyer
estimation and the log rank test (p = 0.000 for both).most of the cases. 
The limitations of this study were as follows. First, the
segmental anatomy was not determined by CT arterio-
portography. However, the decision on the number of
segmental lesions was made by consensus of two experi-
enced abdominal radiologists with tracing the portal
venous tree on the portal phase scan of the spiral CT.
Second, the adjacent segmental or subsegmental arteries of
the tumors were not embolized if definite hypervascular
tumor staining was not noted on the hepatic angiogram.
Employing a unified helical CT/angiography system may
be helpful for this modified embolization procedure (10).
However, more radical treatment might further deteriorate
the hepatic function, and the clinical benefit of this
technique needs to be studied by conducting future
controlled trials. Also, the other ablative therapies such as
RFAT may have been preferable for treating the lesions in
Group I. Third, any enhanced area on the follow-up CT
imaging might have been masked by overlying iodized oil
accumulation in the tumor. 
In conclusion, the local HCC tumor recurrence rate was
higher for the nodules located in the segmental border
zone after treatment with segmental TACE as compared to
the recurrence rate for the nodules located inside hepatic
segments.
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